Published in Immunology on September 01, 1990
Preventing Allograft Rejection by Targeting Immune Metabolism. Cell Rep (2015) 1.02
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cell Mol Immunol (2016) 0.77
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55
The effect of FK-506 on hyperacute rejection in presensitized rats. Transplant Proc (1987) 1.49
Prolongation of canine renal allograft survival by treatment with FK-506. Transplant Proc (1987) 1.38
Studies on FK506 in experimental organ transplantation. Transplant Proc (1988) 1.10
Relationship between concussion and neuropsychological performance in college football players. JAMA (1999) 3.95
Epidemiology of collegiate baseball injuries. Clin J Sport Med (1998) 1.85
In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Leukemia (2004) 1.44
Disturbances of T-cell interactions with endothelium and the extracellular matrix proteins in a patient with Takayasu arteritis. J Intern Med (1994) 1.40
Nasal T-cell lymphoma and the lethal midline granuloma syndrome. Otolaryngol Head Neck Surg (1996) 1.32
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia (2005) 1.31
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma. Blood (2001) 1.27
The influence of external factors on bacteriophages--review. Folia Microbiol (Praha) (2011) 1.22
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. Blood (1998) 1.20
Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood (1998) 1.11
Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Exp (Warsz) (2000) 1.11
BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac. Proc Natl Acad Sci U S A (1998) 1.07
Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis--case report. Folia Microbiol (Praha) (2009) 1.05
Frequency of distribution of inflammatory cytokines IL-1, IL-6 and TNF-alpha gene polymorphism in patients with obstructive sleep apnea. J Physiol Pharmacol (2008) 0.99
Immunomodulating activity of heparin. FASEB J (1991) 0.95
Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura. Hematol J (2001) 0.93
Leptin receptors. Eur J Med Res (2010) 0.93
Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation. Blood (2000) 0.93
The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. Transplant Proc (2007) 0.92
Heterogeneity of antibody response to myobacterial antigens in different clinical manifestations of pulmonary tuberculosis. J Physiol Pharmacol (2007) 0.92
No association of LEPR Gln223Arg polymorphism with leptin, obesity or metabolic disturbances in children. Eur J Med Res (2009) 0.90
Humoral immune response against mycobacterial antigens in children with tuberculosis. J Physiol Pharmacol (2006) 0.89
Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients. J Physiol Pharmacol (2007) 0.89
COX-2 is a novel target in therapy of mycosis fungoides. Leukemia (2010) 0.88
Effect of hepatocyte growth factor on early human haemopoietic cell development. Br J Haematol (1997) 0.87
Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant Proc (2003) 0.87
Possible association between phages, Hoc protein, and the immune system. Arch Virol (2005) 0.86
Injuries in female collegiate swimmers due to swimming and cross training. Clin J Sport Med (1996) 0.86
CD34+, kit+, rhodamine123(low) phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells. Leukemia (1998) 0.86
Expression of CD152 (CTLA-4) in children with autoimmune thyroiditis and +49 A/G polymorphism of exon 1 of the CTLA-4 gene. J Physiol Pharmacol (2009) 0.86
Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br J Cancer (2000) 0.84
Cytomegalovirus pseudotumor presenting as bowel obstruction in a patient with acquired immunodeficiency syndrome. Am J Gastroenterol (1992) 0.84
The role of cow's milk protein intolerance in steroid-resistant nephrotic syndrome. Acta Paediatr (1992) 0.81
Cell culture preparation of human parathyroid cells for allotransplantation without immunosuppression. Transplant Proc (1996) 0.81
Increased expression of adhesion molecule CD18 (LFA-1beta) on the leukocytes of peripheral blood in patients with acute ischemic stroke. Acta Neurol Scand (1998) 0.81
Oral heparin in the treatment of rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) (1995) 0.80
[Some aspects of immune response in toxoplasmosis]. Przegl Epidemiol (2001) 0.80
Altered expression of T lymphocyte surface markers in children with chronic autoimmune thyroiditis. J Physiol Pharmacol (2008) 0.80
The effect of calf thymus extract (TFX) on human and mouse hemopoiesis. Thymus (1981) 0.80
Apoptosis of T cells in the first trimester human decidua. Am J Reprod Immunol (1998) 0.79
Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker--case report. Folia Microbiol (Praha) (2006) 0.79
Cultured parathyroid cell transplantation without immunosuppression in the treatment of surgical hypoparathyroidism. Transplant Proc (1994) 0.79
Molecular modification of T4 bacteriophage proteins and its potential application - review. Folia Microbiol (Praha) (2009) 0.79
Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of lupus erythematosus. Br J Dermatol (1987) 0.79
Heparin enhances generation of natural killer activity in vitro. Arch Immunol Ther Exp (Warsz) (1994) 0.79
Intravenous immunoglobulin therapy influences T cell adhesion to extracellular matrix in women with a history of recurrent spontaneous abortions. Am J Reprod Immunol (2000) 0.79
Association between metabolic disturbances and G-174C polymorphism of interleukin-6 gene in obese children. Eur J Med Res (2009) 0.79
[Cutaneous larva migrans in children in a school of center-western Brazil]. Rev Saude Publica (2000) 0.78
Defective natural-killer- and killer-cell activity associated with increased polymorphonuclear leukocyte adherence in psoriasis. Arch Dermatol Res (1986) 0.78
Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol (1986) 0.78
Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant. Transplant Proc (2006) 0.78
An optimal assay of human B cell proliferation in vitro. J Immunol Methods (1987) 0.78
Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein. Transplant Proc (2011) 0.78
Expression of CD20 on acute lymphoblastic leukemia cells in children. Neoplasma (2001) 0.78
The effect of azathioprine on terminal differentiation of human B lymphocytes. Immunopharmacology (1983) 0.77
Immunological cellular response in denture stomatitis mycotic. Folia Biol (Praha) (1989) 0.77
Influence of proinflammatory cytokine gene polymorphism on childhood obesity. Eur J Med Res (2009) 0.77
Beta 3 integrin expression on T cells from renal allograft recipients. Transplant Proc (2006) 0.77
Immunosuppressive action of low-dose heparin. Effect on skin allograft survival. Transplantation (1990) 0.77
Phages in the global fruit and vegetable industry. J Appl Microbiol (2014) 0.77
HLA antigens and intracranial aneurysms. Acta Neurochir (Wien) (1992) 0.77
Diagnostic and prognostic value of antibody-dependent cellular cytotoxicity and lectin-induced cellular cytotoxicity tests for renal graft rejection. Transplantation (1981) 0.77
Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses. Immunopharmacology (1990) 0.77
[Immunology of ulcerative colitis--interactions of T lymphocytes with extracellular matrix proteins]. Pol Arch Med Wewn (1997) 0.77
Enzyme immunoassay with cell suspensions: studies on reactions between serum antibodies and cell-surface antigens. Int Arch Allergy Appl Immunol (1986) 0.77
Gamma delta + T cells in Wilson's disease. Int J Clin Lab Res (1996) 0.77
Humoral immune response against mycobacterial antigens in bronchoalveolar fluid from tuberculosis patients. J Physiol Pharmacol (2005) 0.77
Autoimmune neutropenia after renal transplantation. Transplantation (1989) 0.77
In vitro humoral responses of renal allograft recipients. Transplant Proc (1987) 0.77
Low dose heparin: efficacious treatment for chronic renal allograft rejection. Arch Immunol Ther Exp (Warsz) (1993) 0.76
Involvement of beta2-microglobulin in CD69 expression on T cells. Arch Immunol Ther Exp (Warsz) (2001) 0.76
Alterations of T-cell: extracellular matrix proteins interactions in psoriasis. Immunol Lett (1993) 0.76
Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of systemic scleroderma. Br J Dermatol (1987) 0.76
Leptin receptor in childhood acute leukemias. Adv Exp Med Biol (2013) 0.76
Immune abnormalities in aneurysmal subarachnoid haemorrhage patients: relation to delayed cerebral vasospasm. Scand J Immunol (2000) 0.76
Neutrophil functions in renal transplant recipients. Arch Immunol Ther Exp (Warsz) (1978) 0.76
New strategies of heparin treatment used to prolong allograft survival. Transplant Proc (1991) 0.76
Allogeneic sensitization alters T-cell reactivity to extracellular matrix proteins in prospective transplant recipients. Transplant Proc (1995) 0.76
Thymosin: an immunomodulator of antibody production in man. Immunology (1982) 0.76
Rejection-associated abnormalities of T-cell interactions with extracellular matrix. Transplant Proc (1995) 0.76
Effect of FK 506 on B-cell responses. Transplant Proc (1991) 0.76
Cytotoxic and antitumor effect of fibrinogen-methotrexate conjugate. Cancer Lett (2000) 0.76
Increased serum fractalkine in systemic sclerosis. Down-regulation by prostaglandin E1. Clin Exp Rheumatol (2008) 0.76
Sublingual immunotherapy in asthma does not influence lymphocyte sensitivity to Fas stimulation. Eur J Med Res (2010) 0.75
Abnormalities in T-cell-ECM interactions in cancer. Immunol Today (1996) 0.75
Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection. Arch Immunol Ther Exp (Warsz) (1978) 0.75
Enhanced clonability of human T lymphocytes caused by their culturing in vitro. Immunology (1981) 0.75
Decreased CD4+CD152+ T cell subset and its correlation with the level of antithyroid antibodies in children with chronic autoimmune thyroiditis. Eur J Med Res (2010) 0.75
Thymosin (TFX) and suppressor cells of immunoglobulin (Ig) production in man. Thymus (1983) 0.75
[Myelopietic regulatory mechanisms]. Pol Arch Med Wewn (1979) 0.75
[Effect of tetanus toxin on the transaminase activity in the liver and amino-nitrogen content of the plasma and erythrocytes in guinea pigs]. Med Dosw Mikrobiol (1983) 0.75
[In vitro erythropoiesis and its disorders]. Pol Tyg Lek (1979) 0.75
Immunoregulatory factors controlling terminal differentiation of malignant B-lymphocytes. Immunol Lett (1983) 0.75
[Effect of tetanus toxin on the plasma levels of protein fractions and electrolytes in guinea pigs]. Med Dosw Mikrobiol (1983) 0.75
[Present-day problems of immunotherapy: transfer factor and levamisole]. Pol Arch Med Wewn (1976) 0.75